Symbol:
Asxl2
Name:
ASXL transcriptional regulator 2
RGD ID:
1304710
Description:
Predicted to enable chromatin binding activity and peroxisome proliferator activated receptor binding activity. Involved in positive regulation of lipid storage. Predicted to be located in nucleoplasm. Predicted to be part of PR-DUB complex. Orthologous to human ASXL2 (ASXL transcriptional regulator 2); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; gentamycin; valproic acid.
Type:
protein-coding
RefSeq Status:
MODEL
Previously known as:
additional sex combs like 2; additional sex combs like 2 (Drosophila); additional sex combs like 2, transcriptional regulator; additional sex combs like transcriptional regulator 2; LOC313922; putative Polycomb group protein ASXL2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 6 32,090,497 - 32,234,487 (+) NCBI GRCr8 mRatBN7.2 6 26,425,017 - 26,514,899 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 6 26,425,954 - 26,507,477 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 6 27,835,346 - 27,919,285 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 6 27,887,797 - 27,915,563 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 6 37,644,433 - 37,732,264 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 6 26,400,855 - 26,482,465 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 6 26,470,864 - 26,484,531 (+) NCBI Celera 6 25,902,447 - 25,987,120 (+) NCBI Celera Cytogenetic Map 6 q14 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Asxl2 Rat (+)-catechin multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in decreased expression of ASXL2 mRNA CTD PMID:24763279 Asxl2 Rat 1,2-dimethylhydrazine multiple interactions ISO Asxl2 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ASXL2 mRNA CTD PMID:22206623 Asxl2 Rat 1,2-dimethylhydrazine decreases expression ISO Asxl2 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of ASXL2 mRNA CTD PMID:22206623 Asxl2 Rat 1-Hydroxypyrene decreases expression ISO ASXL2 (Homo sapiens) 6480464 1-hydroxypyrene results in decreased expression of ASXL2 mRNA CTD PMID:21854004 Asxl2 Rat 2,2',4,4'-Tetrabromodiphenyl ether multiple interactions ISO Asxl2 (Mus musculus) 6480464 [Flame Retardants results in increased abundance of 2 more ... CTD PMID:38995820 Asxl2 Rat 2,3',4,4',5-Pentachlorobiphenyl increases expression ISO Asxl2 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Asxl2 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Asxl2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of ASXL2 mRNA CTD PMID:21570461 Asxl2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ASXL2 mRNA CTD PMID:32109520 Asxl2 Rat 2-hydroxypropanoic acid decreases expression ISO ASXL2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ASXL2 mRNA CTD PMID:30851411 Asxl2 Rat 2-methylcholine affects expression ISO ASXL2 (Homo sapiens) 6480464 beta-methylcholine affects the expression of ASXL2 mRNA CTD PMID:21179406 Asxl2 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA CTD PMID:28628672 Asxl2 Rat aflatoxin B1 increases expression ISO Asxl2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of ASXL2 mRNA CTD PMID:19770486 Asxl2 Rat aflatoxin B1 increases methylation ISO ASXL2 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of ASXL2 gene CTD PMID:27153756 Asxl2 Rat aristolochic acid A decreases expression ISO ASXL2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of ASXL2 mRNA CTD PMID:33212167 Asxl2 Rat arsane multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA CTD PMID:39836092 Asxl2 Rat arsenic atom multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA CTD PMID:39836092 Asxl2 Rat arsenous acid increases expression ISO ASXL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ASXL2 mRNA CTD PMID:20458559 Asxl2 Rat atrazine decreases expression ISO ASXL2 (Homo sapiens) 6480464 Atrazine results in decreased expression of ASXL2 mRNA CTD PMID:22378314 Asxl2 Rat benzo[a]pyrene increases expression ISO Asxl2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of ASXL2 mRNA CTD PMID:22228805 Asxl2 Rat benzo[a]pyrene decreases expression ISO ASXL2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of ASXL2 mRNA CTD PMID:30453624 Asxl2 Rat benzo[a]pyrene diol epoxide I decreases expression ISO ASXL2 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20018196 Asxl2 Rat benzo[a]pyrene diol epoxide I increases expression ISO ASXL2 (Homo sapiens) 6480464 7 more ... CTD PMID:26238291 Asxl2 Rat benzo[e]pyrene decreases methylation ISO ASXL2 (Homo sapiens) 6480464 benzo(e)pyrene results in decreased methylation of ASXL2 intron CTD PMID:30157460 Asxl2 Rat bisphenol A increases expression ISO Asxl2 (Mus musculus) 6480464 bisphenol A results in increased expression of ASXL2 mRNA CTD PMID:35598803 Asxl2 Rat bisphenol F multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA CTD PMID:28628672 Asxl2 Rat cadmium atom multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASXL2 mRNA CTD PMID:35301059 Asxl2 Rat cadmium dichloride multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ASXL2 mRNA CTD PMID:35301059 Asxl2 Rat caffeine affects phosphorylation ISO ASXL2 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of ASXL2 protein CTD PMID:35688186 Asxl2 Rat carbon nanotube decreases expression ISO Asxl2 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 Asxl2 Rat CGP 52608 multiple interactions ISO ASXL2 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to ASXL2 gene] CTD PMID:28238834 Asxl2 Rat choline multiple interactions ISO Asxl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene CTD PMID:20938992 Asxl2 Rat cisplatin decreases phosphorylation ISO Asxl2 (Mus musculus) 6480464 Cisplatin results in decreased phosphorylation of ASXL2 protein CTD PMID:22006019 Asxl2 Rat cisplatin decreases expression ISO ASXL2 (Homo sapiens) 6480464 Cisplatin results in decreased expression of ASXL2 mRNA CTD PMID:27594783 Asxl2 Rat copper(II) sulfate increases expression ISO ASXL2 (Homo sapiens) 6480464 Copper Sulfate results in increased expression of ASXL2 mRNA CTD PMID:19549813 Asxl2 Rat dexamethasone multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA CTD PMID:28628672 Asxl2 Rat diarsenic trioxide increases expression ISO ASXL2 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of ASXL2 mRNA CTD PMID:20458559 Asxl2 Rat Dibutyl phosphate affects expression ISO ASXL2 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of ASXL2 mRNA CTD PMID:37042841 Asxl2 Rat dicrotophos increases expression ISO ASXL2 (Homo sapiens) 6480464 dicrotophos results in increased expression of ASXL2 mRNA CTD PMID:28302478 Asxl2 Rat dorsomorphin multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA CTD PMID:27188386 Asxl2 Rat elemental selenium decreases expression ISO ASXL2 (Homo sapiens) 6480464 Selenium results in decreased expression of ASXL2 mRNA CTD PMID:19244175 Asxl2 Rat ferroheme b decreases expression ISO Asxl2 (Mus musculus) 6480464 Heme metabolite results in decreased expression of ASXL2 mRNA CTD PMID:19191707 Asxl2 Rat folic acid multiple interactions ISO Asxl2 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Asxl2 Rat FR900359 affects phosphorylation ISO ASXL2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of ASXL2 protein CTD PMID:37730182 Asxl2 Rat gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ASXL2 mRNA CTD PMID:33387578 Asxl2 Rat heme b decreases expression ISO Asxl2 (Mus musculus) 6480464 Heme metabolite results in decreased expression of ASXL2 mRNA CTD PMID:19191707 Asxl2 Rat hexadecanoic acid decreases phosphorylation ISO ASXL2 (Homo sapiens) 6480464 Palmitic Acid results in decreased phosphorylation of ASXL2 protein CTD PMID:28073184 Asxl2 Rat indometacin multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ASXL2 mRNA CTD PMID:28628672 Asxl2 Rat L-methionine multiple interactions ISO Asxl2 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of ASXL2 gene CTD PMID:20938992 Asxl2 Rat manganese atom multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA CTD PMID:39836092 Asxl2 Rat manganese(0) multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA CTD PMID:39836092 Asxl2 Rat manganese(II) chloride multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA and [manganese chloride results in increased abundance of Manganese] which results in decreased expression of ASXL2 mRNA CTD PMID:39836092 Asxl2 Rat methapyrilene decreases methylation ISO ASXL2 (Homo sapiens) 6480464 Methapyrilene results in decreased methylation of ASXL2 intron CTD PMID:30157460 Asxl2 Rat methyl methanesulfonate increases expression ISO ASXL2 (Homo sapiens) 6480464 Methyl Methanesulfonate results in increased expression of ASXL2 mRNA CTD PMID:23649840 Asxl2 Rat ozone multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [Air Pollutants results in increased abundance of Ozone] which affects the expression of ASXL2 mRNA CTD PMID:35430440 Asxl2 Rat paracetamol affects expression ISO Asxl2 (Mus musculus) 6480464 Acetaminophen affects the expression of ASXL2 mRNA CTD PMID:17562736 Asxl2 Rat phenobarbital affects expression ISO Asxl2 (Mus musculus) 6480464 Phenobarbital affects the expression of ASXL2 mRNA CTD PMID:23091169 Asxl2 Rat rac-lactic acid decreases expression ISO ASXL2 (Homo sapiens) 6480464 Lactic Acid results in decreased expression of ASXL2 mRNA CTD PMID:30851411 Asxl2 Rat SB 431542 multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA CTD PMID:27188386 Asxl2 Rat selenium atom decreases expression ISO ASXL2 (Homo sapiens) 6480464 Selenium results in decreased expression of ASXL2 mRNA CTD PMID:19244175 Asxl2 Rat silver atom increases expression ISO ASXL2 (Homo sapiens) 6480464 Silver results in increased expression of ASXL2 mRNA CTD PMID:26014281 Asxl2 Rat silver(0) increases expression ISO ASXL2 (Homo sapiens) 6480464 Silver results in increased expression of ASXL2 mRNA CTD PMID:26014281 Asxl2 Rat sodium arsenite increases expression ISO ASXL2 (Homo sapiens) 6480464 sodium arsenite results in increased expression of ASXL2 mRNA CTD PMID:38568856 Asxl2 Rat sodium arsenite multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased abundance of Manganese]] results in decreased expression of ASXL2 mRNA and [sodium arsenite results in increased abundance of Arsenic] which results in decreased expression of ASXL2 mRNA CTD PMID:39836092 Asxl2 Rat titanium dioxide decreases methylation ISO Asxl2 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of ASXL2 gene CTD PMID:35295148 Asxl2 Rat trichostatin A increases expression ISO ASXL2 (Homo sapiens) 6480464 trichostatin A results in increased expression of ASXL2 mRNA CTD PMID:24935251 Asxl2 Rat triphenyl phosphate affects expression ISO ASXL2 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of ASXL2 mRNA CTD PMID:37042841 Asxl2 Rat troglitazone decreases expression ISO Asxl2 (Mus musculus) 6480464 troglitazone results in decreased expression of ASXL2 mRNA CTD PMID:28973697 Asxl2 Rat tungsten decreases expression ISO Asxl2 (Mus musculus) 6480464 Tungsten results in decreased expression of ASXL2 mRNA CTD PMID:30912803 Asxl2 Rat valproic acid increases expression ISO ASXL2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of ASXL2 mRNA CTD PMID:23179753 and PMID:26272509 Asxl2 Rat valproic acid multiple interactions ISO ASXL2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ASXL2 mRNA CTD PMID:27188386 Asxl2 Rat valproic acid affects splicing EXP 6480464 Valproic Acid affects the splicing of ASXL2 mRNA CTD PMID:29427782
(+)-catechin (ISO) 1,2-dimethylhydrazine (ISO) 1-Hydroxypyrene (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-hydroxypropanoic acid (ISO) 2-methylcholine (ISO) 3-isobutyl-1-methyl-7H-xanthine (ISO) aflatoxin B1 (ISO) aristolochic acid A (ISO) arsane (ISO) arsenic atom (ISO) arsenous acid (ISO) atrazine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[e]pyrene (ISO) bisphenol A (ISO) bisphenol F (ISO) cadmium atom (ISO) cadmium dichloride (ISO) caffeine (ISO) carbon nanotube (ISO) CGP 52608 (ISO) choline (ISO) cisplatin (ISO) copper(II) sulfate (ISO) dexamethasone (ISO) diarsenic trioxide (ISO) Dibutyl phosphate (ISO) dicrotophos (ISO) dorsomorphin (ISO) elemental selenium (ISO) ferroheme b (ISO) folic acid (ISO) FR900359 (ISO) gentamycin (EXP) heme b (ISO) hexadecanoic acid (ISO) indometacin (ISO) L-methionine (ISO) manganese atom (ISO) manganese(0) (ISO) manganese(II) chloride (ISO) methapyrilene (ISO) methyl methanesulfonate (ISO) ozone (ISO) paracetamol (ISO) phenobarbital (ISO) rac-lactic acid (ISO) SB 431542 (ISO) selenium atom (ISO) silver atom (ISO) silver(0) (ISO) sodium arsenite (ISO) titanium dioxide (ISO) trichostatin A (ISO) triphenyl phosphate (ISO) troglitazone (ISO) tungsten (ISO) valproic acid (EXP,ISO)
Asxl2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 6 32,090,497 - 32,234,487 (+) NCBI GRCr8 mRatBN7.2 6 26,425,017 - 26,514,899 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 6 26,425,954 - 26,507,477 (+) Ensembl mRatBN7.2 Ensembl Rnor_6.0 6 27,835,346 - 27,919,285 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 6 27,887,797 - 27,915,563 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 6 37,644,433 - 37,732,264 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 6 26,400,855 - 26,482,465 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 6 26,470,864 - 26,484,531 (+) NCBI Celera 6 25,902,447 - 25,987,120 (+) NCBI Celera Cytogenetic Map 6 q14 NCBI
ASXL2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 2 25,733,753 - 25,878,487 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 2 25,733,753 - 25,878,487 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 2 25,956,622 - 26,101,356 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 2 25,815,757 - 25,954,816 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 2 25,873,909 - 26,013,007 NCBI Celera 2 25,802,588 - 25,941,650 (-) NCBI Celera Cytogenetic Map 2 p23.3 NCBI HuRef 2 25,699,339 - 25,838,712 (-) NCBI HuRef CHM1_1 2 25,891,914 - 26,030,899 (-) NCBI CHM1_1 T2T-CHM13v2.0 2 25,769,050 - 25,913,813 (-) NCBI T2T-CHM13v2.0
Asxl2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 12 3,476,892 - 3,560,811 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 12 3,476,857 - 3,556,852 (+) Ensembl GRCm39 Ensembl GRCm38 12 3,426,857 - 3,510,811 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 12 3,426,857 - 3,506,852 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 12 3,426,884 - 3,506,849 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 12 3,426,901 - 3,502,468 (+) NCBI MGSCv36 mm8 Celera 12 3,353,949 - 3,434,249 (+) NCBI Celera Cytogenetic Map 12 A1.1 NCBI cM Map 12 1.81 NCBI
Asxl2 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955469 7,786,154 - 7,923,500 (-) Ensembl ChiLan1.0 ChiLan1.0 NW_004955469 7,786,030 - 7,923,739 (-) NCBI ChiLan1.0 ChiLan1.0
ASXL2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 12 100,638,203 - 100,792,850 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 2A 100,642,167 - 100,796,817 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 2A 25,730,155 - 25,880,089 (-) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 2A 25,824,278 - 25,973,659 (-) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 2A 25,832,527 - 25,973,659 (-) Ensembl panpan1.1 panPan2
ASXL2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 17 19,914,026 - 20,065,141 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 17 19,895,568 - 20,044,691 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 17 19,810,081 - 19,960,956 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 17 20,235,589 - 20,386,543 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 17 20,244,106 - 20,366,511 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 17 19,923,297 - 20,074,379 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 17 19,932,920 - 20,084,155 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 17 19,978,936 - 20,130,179 (-) NCBI UU_Cfam_GSD_1.0
Asxl2 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024406292 64,237,321 - 64,375,709 (-) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936493 6,463,744 - 6,594,252 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936493 6,463,771 - 6,602,244 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
ASXL2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 3 113,044,836 - 113,180,742 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 3 113,044,788 - 113,184,809 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 3 119,991,762 - 120,173,786 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
ASXL2
Asxl2
.
Predicted Target Of
Count of predictions: 42 Count of miRNA genes: 20 Interacting mature miRNAs: 21 Transcripts: ENSRNOT00000015827, ENSRNOT00000061505 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
8552962 Pigfal16 Plasma insulin-like growth factor 1 level QTL 16 9.4 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 6 1 41223769 Rat 1549905 Stresp10 Stress response QTL 10 6.83 0.0066 stress-related behavior trait (VT:0010451) number of approaches toward negative stimulus before onset of defensive burying response (CMO:0001960) 6 1 27574569 Rat 10401812 Kidm54 Kidney mass QTL 54 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 6 14368788 59368788 Rat 1331743 Uae28 Urinary albumin excretion QTL 28 4.5 urine albumin amount (VT:0002871) urine albumin level (CMO:0000130) 6 1 34235784 Rat 2292589 Emca10 Estrogen-induced mammary cancer QTL 10 0.048 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 6 16536140 61536140 Rat 10401800 Kidm49 Kidney mass QTL 49 kidney mass (VT:0002707) both kidneys wet weight (CMO:0000085) 6 14368788 59368788 Rat 1300164 Rf15 Renal function QTL 15 3.12 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 6 5074497 54641141 Rat 9589129 Insul24 Insulin level QTL 24 19.06 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 6 1 41223769 Rat 1578758 Tcas9 Tongue tumor susceptibility QTL 9 3.29 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 6 1 37618905 Rat 4145119 Mcs25 Mammary carcinoma susceptibility QTL 25 0.0001 mammary gland integrity trait (VT:0010552) ratio of deaths to total study population during a period of time (CMO:0001023) 6 10894415 110548006 Rat 7411603 Foco13 Food consumption QTL 13 5.5 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 6 1 41223769 Rat 1598843 Cm63 Cardiac mass QTL 63 2.6 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 6 1 39036266 Rat 738024 Sach5 Saccharine consumption QTL 5 3.9 0.00039 consumption behavior trait (VT:0002069) saccharin intake volume to total fluid intake volume ratio (CMO:0001601) 6 1 43394190 Rat 7411542 Bw127 Body weight QTL 127 5.5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 6 1 41223769 Rat 9589048 Scfw3 Subcutaneous fat weight QTL 3 4.57 0.001 subcutaneous adipose mass (VT:1000472) abdominal subcutaneous fat pad weight (CMO:0002069) 6 1 41223769 Rat 738023 Alc17 Alcohol consumption QTL 17 3.1 0.003 consumption behavior trait (VT:0002069) ethanol drink intake rate to body weight ratio (CMO:0001616) 6 1 27574569 Rat 1354616 Despr12 Despair related QTL 12 0.0012 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 6 1 27574569 Rat 2293839 Kiddil2 Kidney dilation QTL 2 4.8 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 6 20866422 81133036 Rat 1576309 Emca7 Estrogen-induced mammary cancer QTL 7 4 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 6 15107216 107351382 Rat 2293709 Bss23 Bone structure and strength QTL 23 5.18 0.0001 femur morphology trait (VT:0000559) femur cross-sectional area (CMO:0001661) 6 1 42487980 Rat 2293650 Bss31 Bone structure and strength QTL 31 5.05 0.0001 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 6 1 42487980 Rat 7411584 Foco4 Food consumption QTL 4 4.3 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 6 1 42838846 Rat 1578665 Bss16 Bone structure and strength QTL 16 4.4 femur morphology trait (VT:0000559) bone trabecular cross-sectional area (CMO:0002311) 6 11735669 72593685 Rat 2293841 Kiddil4 Kidney dilation QTL 4 4.4 kidney pelvis morphology trait (VT:0004194) hydronephrosis severity score (CMO:0001208) 6 20866422 81133036 Rat 2300176 Bmd51 Bone mineral density QTL 51 11.7 0.0001 femur mineral mass (VT:0010011) bone mineral density (CMO:0001226) 6 1 27574569 Rat 1300128 Rf16 Renal function QTL 16 3.89 renal blood flow trait (VT:2000006) absolute change in renal blood flow rate (CMO:0001168) 6 5074497 34434305 Rat 1641898 Colcr4 Colorectal carcinoma resistance QTL4 3.71 0.0007 intestine integrity trait (VT:0010554) well differentiated malignant colorectal tumor surface area measurement (CMO:0002077) 6 20338777 62613667 Rat 1578668 Bmd14 Bone mineral density QTL 14 3.8 femur mineral mass (VT:0010011) total volumetric bone mineral density (CMO:0001728) 6 11735669 72593685 Rat 2301972 Bp325 Blood pressure QTL 325 4.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 6 1 72227641 Rat 2293656 Bss28 Bone structure and strength QTL 28 6.79 0.0001 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 6 1 42487980 Rat 1359023 Bp272 Blood pressure QTL 272 2.5 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 6 16536140 27261739 Rat 1354664 Slep2 Serum leptin concentration QTL 2 4.49 blood leptin amount (VT:0005667) serum leptin level (CMO:0000780) 6 16536140 71636405 Rat 2300190 Bmd52 Bone mineral density QTL 52 11.2 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 6 1 27574569 Rat
BF404323
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 6 26,425,745 - 26,425,935 (+) MAPPER mRatBN7.2 Rnor_6.0 6 27,835,324 - 27,835,513 NCBI Rnor6.0 Rnor_5.0 6 37,645,596 - 37,645,785 UniSTS Rnor5.0 RGSC_v3.4 6 26,400,946 - 26,401,135 UniSTS RGSC3.4 Celera 6 25,902,425 - 25,902,614 UniSTS RH 3.4 Map 6 117.39 UniSTS Cytogenetic Map 6 q14 UniSTS
BF399538
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 6 26,425,599 - 26,425,768 (+) MAPPER mRatBN7.2 Rnor_6.0 6 27,835,178 - 27,835,346 NCBI Rnor6.0 Rnor_5.0 6 37,645,450 - 37,645,618 UniSTS Rnor5.0 RGSC_v3.4 6 26,400,800 - 26,400,968 UniSTS RGSC3.4 Celera 6 25,902,279 - 25,902,447 UniSTS RH 3.4 Map 6 116.9 UniSTS Cytogenetic Map 6 q14 UniSTS
AU048346
Rat Assembly Chr Position (strand) Source JBrowse Rnor_6.0 6 27,856,385 - 27,856,508 NCBI Rnor6.0 Rnor_5.0 6 37,666,657 - 37,666,780 UniSTS Rnor5.0 RGSC_v3.4 6 26,422,007 - 26,422,131 UniSTS RGSC3.4 Celera 6 25,923,486 - 25,923,610 UniSTS Cytogenetic Map 6 q14 UniSTS
RH140747
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 6 26,426,076 - 26,426,222 (+) MAPPER mRatBN7.2 Rnor_6.0 6 27,835,655 - 27,835,800 NCBI Rnor6.0 Rnor_5.0 6 37,645,927 - 37,646,072 UniSTS Rnor5.0 RGSC_v3.4 6 26,401,277 - 26,401,422 UniSTS RGSC3.4 Celera 6 25,902,756 - 25,902,901 UniSTS RH 3.4 Map 6 117.5 UniSTS Cytogenetic Map 6 q14 UniSTS
Asxl2DS-g-a-48f06_r1_177
Rat Assembly Chr Position (strand) Source JBrowse RGSC_v3.4 6 26,458,168 - 26,458,168 (+) RGD RGSC3.4
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000015827 ⟹ ENSRNOP00000015827
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 6 26,460,689 - 26,507,477 (+) Ensembl Rnor_6.0 Ensembl 6 27,887,797 - 27,915,563 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000105980 ⟹ ENSRNOP00000081020
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 6 26,425,954 - 26,507,477 (+) Ensembl
RefSeq Acc Id:
XM_063262610 ⟹ XP_063118680
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,144,276 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262611 ⟹ XP_063118681
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,144,276 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262612 ⟹ XP_063118682
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,090,497 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262613 ⟹ XP_063118683
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,160,204 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262614 ⟹ XP_063118684
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,168,740 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262615 ⟹ XP_063118685
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,168,740 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262616 ⟹ XP_063118686
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,168,740 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262617 ⟹ XP_063118687
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,168,738 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262618 ⟹ XP_063118688
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,174,354 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262619 ⟹ XP_063118689
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,200,678 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XM_063262620 ⟹ XP_063118690
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,213,209 - 32,234,487 (+) NCBI
RefSeq Acc Id:
XR_010052213
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 6 32,144,276 - 32,234,487 (+) NCBI
Ensembl Acc Id:
ENSRNOP00000015827 ⟸ ENSRNOT00000015827
Ensembl Acc Id:
ENSRNOP00000081020 ⟸ ENSRNOT00000105980
RefSeq Acc Id:
XP_063118682 ⟸ XM_063262612
- Peptide Label:
isoform X3
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118680 ⟸ XM_063262610
- Peptide Label:
isoform X1
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118681 ⟸ XM_063262611
- Peptide Label:
isoform X2
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118683 ⟸ XM_063262613
- Peptide Label:
isoform X3
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118687 ⟸ XM_063262617
- Peptide Label:
isoform X4
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118686 ⟸ XM_063262616
- Peptide Label:
isoform X4
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118685 ⟸ XM_063262615
- Peptide Label:
isoform X4
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118684 ⟸ XM_063262614
- Peptide Label:
isoform X4
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118688 ⟸ XM_063262618
- Peptide Label:
isoform X4
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118689 ⟸ XM_063262619
- Peptide Label:
isoform X5
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
RefSeq Acc Id:
XP_063118690 ⟸ XM_063262620
- Peptide Label:
isoform X6
- UniProtKB:
D3Z8N9 (UniProtKB/TrEMBL)
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2018-05-18
Asxl2
ASXL transcriptional regulator 2
Asxl2
additional sex combs like 2, transcriptional regulator
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2015-12-02
Asxl2
additional sex combs like 2, transcriptional regulator
Asxl2
additional sex combs like transcriptional regulator 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2014-06-25
Asxl2
additional sex combs like transcriptional regulator 2
Asxl2
additional sex combs like 2 (Drosophila)
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-04-30
Asxl2
additional sex combs like 2 (Drosophila)
Asxl2_predicted
additional sex combs like 2 (Drosophila) (predicted)
'predicted' is removed
2292626 APPROVED
2005-01-12
Asxl2_predicted
additional sex combs like 2 (Drosophila) (predicted)
Symbol and Name status set to approved
70820 APPROVED
